Your browser doesn't support javascript.
loading
Hematopoietic mosaic chromosomal alterations and risk for infection among 767,891 individuals without blood cancer.
Zekavat, Seyedeh M; Lin, Shu-Hong; Bick, Alexander G; Liu, Aoxing; Paruchuri, Kaavya; Uddin, Md Mesbah; Ye, Yixuan; Yu, Zhaolong; Liu, Xiaoxi; Kamatani, Yoichiro; Pirruccello, James P; Pampana, Akhil; Loh, Po-Ru; Kohli, Puja; McCarroll, Steven A; Neale, Benjamin; Engels, Eric A; Brown, Derek W; Smoller, Jordan W; Green, Robert; Karlson, Elizabeth W; Lebo, Matthew; Ellinor, Patrick T; Weiss, Scott T; Daly, Mark J; Terao, Chikashi; Zhao, Hongyu; Ebert, Benjamin L; Ganna, Andrea; Machiela, Mitchell J; Genovese, Giulio; Natarajan, Pradeep.
Afiliação
  • Zekavat SM; Computational Biology & Bioinformatics Program, Yale University, New Haven, CT.
  • Lin SH; Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA.
  • Bick AG; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA.
  • Liu A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD.
  • Paruchuri K; Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center.
  • Uddin MM; Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA.
  • Ye Y; Institute for Molecular Medicine Finland, Helsinki, Finland.
  • Yu Z; Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA.
  • Liu X; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA.
  • Kamatani Y; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Pirruccello JP; Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA.
  • Pampana A; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA.
  • Loh PR; Computational Biology & Bioinformatics Program, Yale University, New Haven, CT.
  • Kohli P; Computational Biology & Bioinformatics Program, Yale University, New Haven, CT.
  • McCarroll SA; Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
  • Neale B; Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan.
  • Engels EA; Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA.
  • Brown DW; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA.
  • Smoller JW; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Green R; Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA.
  • Karlson EW; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA.
  • Lebo M; Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA.
  • Ellinor PT; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Weiss ST; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA.
  • Daly MJ; Vertex Pharmaceuticals, Boston, MA.
  • Terao C; Stanley Center, Broad Institute of Harvard and MIT, Cambridge, MA.
  • Zhao H; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA.
  • Ebert BL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD.
  • Ganna A; Stanley Center, Broad Institute of Harvard and MIT, Cambridge, MA.
  • Machiela MJ; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA.
  • Genovese G; Department of Psychiatry, Harvard Medical School, Boston, MA.
  • Natarajan P; Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA.
medRxiv ; 2020 Nov 16.
Article em En | MEDLINE | ID: mdl-33236019
Age is the dominant risk factor for infectious diseases, but the mechanisms linking the two are incompletely understood1,2. Age-related mosaic chromosomal alterations (mCAs) detected from blood-derived DNA genotyping, are structural somatic variants associated with aberrant leukocyte cell counts, hematological malignancy, and mortality3-11. Whether mCAs represent independent risk factors for infection is unknown. Here we use genome-wide genotyping of blood DNA to show that mCAs predispose to diverse infectious diseases. We analyzed mCAs from 767,891 individuals without hematological cancer at DNA acquisition across four countries. Expanded mCA (cell fraction >10%) prevalence approached 4% by 60 years of age and was associated with diverse incident infections, including sepsis, pneumonia, and coronavirus disease 2019 (COVID-19) hospitalization. A genome-wide association study of expanded mCAs identified 63 significant loci. Germline genetic alleles associated with expanded mCAs were enriched at transcriptional regulatory sites for immune cells. Our results link mCAs with impaired immunity and predisposition to infections. Furthermore, these findings may also have important implications for the ongoing COVID-19 pandemic, particularly in prioritizing individual preventive strategies and evaluating immunization responses.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: MedRxiv Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: MedRxiv Ano de publicação: 2020 Tipo de documento: Article